HER-2/NEU IN TISSUE AND SERUM AT TIME OF PRIMARY DIAGNOSIS OF BREAST CANCER

被引：0
|
作者：
Dresse, M. [1 ]
Mayr, D. [2 ]
Heinemann, V. [3 ]
Kahlert, S. [4 ]
Bauerfeind, I. [4 ]
Nagel, D. [1 ]
Seidel, D. [1 ]
Stieber, P. [1 ]
机构：
[1] Univ Hosp, Inst Clin Chem, Munich, Germany
[2] Univ Hosp, Inst Pathol, Munich, Germany
[3] Univ Hosp, Dept Med 3, Munich, Germany
[4] Univ Hosp, Dept Gynecol, Munich, Germany
来源：
ANTICANCER RESEARCH | 2008年 / 28卷 / 6B期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
33
引用
收藏
页码：4027 / 4027
页数：1
相关论文
共 50 条
  • [21] Clinical use of the serum marker HER-2/NEU in patients with breast cancer
    Dalu, D.
    Cattaneo, M. T.
    Piazza, E.
    Piva, S.
    Gambaro, A.
    Tosca, N.
    Gabris, A.
    Filipazzi, V
    Esani, G.
    Somma, L.
    Sarnataro, C.
    Zambelli, S.
    Damiani, E.
    ANNALS OF ONCOLOGY, 2007, 18 : 45 - 45
  • [22] Expression and Significance of HER-2/neu and RECK Proteins in Breast Cancer Tissue
    Shen Bo
    Wei Da
    Xu Xinyu
    Zheng Maqing
    Feng Jifeng
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2013, 1 (03): : 76 - 78
  • [23] Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy
    Mazouni, Chafika
    Hall, Angeline
    Broglio, Kristine
    Fritsche, Herbert
    Andre, Fabrice
    Esteva, Francisco J.
    Hortobagyi, Gabriel N.
    Buzdar, Aman U.
    Pusztai, Lajos
    Cristofanilli, Massimo
    CANCER, 2007, 109 (03) : 496 - 501
  • [24] Serum HER-2/neu levels correlate with time to progression in therapy of metastatic breast cancer.
    Schippinger, W
    Bauernhofer, T
    Ploner, F
    Hofmann, G
    Krippl, P
    Neumann, R
    Wernecke, KD
    Samonigg, H
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S104 - S104
  • [25] Comparison of serum and tissue HER-2/neu expression in breast and prostate cancers.
    Neaman, IE
    Contois, JH
    Smith, C
    Schwartz, D
    Schwartz, MK
    Yeung, KK
    Allard, WJ
    CLINICAL CHEMISTRY, 2000, 46 (06) : A162 - A162
  • [26] Amplification of HER-2/neu and Topoisomerase IIα in primary and metastatic breast cancer
    Tanner, M
    Järvinen, P
    Isola, J
    CANCER RESEARCH, 2001, 61 (14) : 5345 - 5348
  • [27] Patterns of HER-2/neu amplification and overexpression in primary and metastatic breast cancer
    Simon, R
    Nocito, A
    Hübscher, T
    Bucher, C
    Torhorst, J
    Schraml, P
    Bubendorf, L
    Mihatsch, MM
    Moch, H
    Wilber, K
    Schötzau, A
    Kononen, J
    Sauter, G
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (15) : 1141 - 1146
  • [28] Profiling serum HER-2/NEU in prostate cancer
    Siampanopoulou, M.
    Galaktidou, G.
    Dimasis, N.
    Gotzamani-Psarrakou, A.
    HIPPOKRATIA, 2013, 17 (02) : 108 - 112
  • [29] HER-2/neu gene product in serum - An oncoprotein in the diagnosis and therapy of breast carcinoma
    Schulze, G
    ANTICANCER RESEARCH, 2003, 23 (2A) : 1007 - 1010
  • [30] Serum HER-2 concentration in patients with primary breast cancer
    Kong, SY
    Kang, JH
    Kwon, Y
    Kang, HS
    Chung, KW
    Kang, SH
    Lee, DH
    Ro, J
    Lee, ES
    JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (04) : 373 - 376
12345